Related Experiment Video
Updated: May 18, 2026

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
Published on: September 13, 2019
Identification of FoxM1/Bub1b signaling pathway as a required component for growth and survival of rhabdomyosarcoma
Xiaolin Wan1, Choh Yeung, Su Young Kim
1Molecular Oncology Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. xiaolinw@mail.nih.gov
Abstract:
We identified Bub1b as an essential element for the growth and survival of rhabdomyosarcoma (RMS) cells using a bar-coded, tetracycline-inducible short hairpin RNA (shRNA) library screen. Knockdown of Bub1b resulted in suppression of tumor growth in vivo, including the regression of established tumors. The mechanism by which this occurs is via postmitotic endoreduplication checkpoint and mitotic catastrophe. Furthermore, using a chromatin immunoprecipitation assay, we found that Bub1b is a direct transcriptional target of Forkhead Box M1 (FoxM1). Suppression of FoxM1 either by shRNA or the inhibitor siomycin A resulted in reduction of Bub1b expression and inhibition of cell growth and survival. These results show the important role of the Bub1b/FoxM1 pathway in RMS and provide potential therapeutic targets.
Insights
Bub1b is crucial for rhabdomyosarcoma (RMS) cell growth. Inhibiting Bub1b or its regulator FoxM1 halts tumor progression, offering potential new therapies for RMS.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Rhabdomyosarcoma (RMS) is a pediatric cancer.
- Identifying novel therapeutic targets is critical for improving RMS treatment outcomes.
Purpose of the Study:
- To identify essential genes for rhabdomyosarcoma (RMS) cell growth and survival.
- To investigate the role of Bub1b and its regulatory pathway in RMS.
Main Methods:
- Utilized a bar-coded, tetracycline-inducible short hairpin RNA (shRNA) library screen to identify essential genes in RMS.
- Performed knockdown experiments of Bub1b and Forkhead Box M1 (FoxM1).
- Employed chromatin immunoprecipitation (ChIP) assays to determine transcriptional regulation.
Main Results:
- Bub1b was identified as essential for RMS cell proliferation and survival.
- Knockdown of Bub1b suppressed tumor growth in vivo and led to tumor regression.
- Bub1b was confirmed as a direct transcriptional target of FoxM1.
- Suppression of FoxM1 reduced Bub1b expression and inhibited RMS cell growth.
Conclusions:
- The Bub1b/FoxM1 pathway plays a critical role in rhabdomyosarcoma.
- Targeting this pathway presents a promising therapeutic strategy for RMS treatment.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
Hedgehog Signaling Pathway
Hedgehog Signaling Pathway
